Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

Table 5 Incremental effects of GA, FBG, and HbA1c on risk stratification for the MACCE beyond existing risk factors

	Chi-square value	Harrell’s C-index			Continuous-NRI			IDI
	Chi-square value	Estimation	95% CI	P for comparison	Estimation	95% CI	P value	Estimation	95% CI	P value
Baseline model	235.533	0.684	0.663–0.706	–	–	–	–	–	–	–
+ GA	260.704	0.694	0.673–0.715	0.002	0.085	− 0.004–0.138	0.053	0.007	0.001–0.017	0.020
+ FBG	257.774	0.692	0.671–0.713	0.001	0.087	− 0.002–0.144	0.053	0.005	0.000–0.013	0.040
+ HbA1c	258.198	0.693	0.672–0.714	0.005	0.048	− 0.012–0.103	0.106	0.006	0.001–0.014	0.033

The baseline model included age, gender, BMI, smoking history, family history of CAD, hypertension, T2DM, anemia, NSTEMI, creatinine, TC, LVEF, LM lesion, multi-vessel lesion and SYNTAX score
NRI net reclassification improvement, IDI integrated discrimination improvement, CI confidence interval
GA glycated albumin, FBG fasting blood glucose, HbA1c glycosylated hemoglobin A1c

ISSN: 1475-2840